Mesothelioma IHC — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Retention does not exclude mesothelioma; loss of BAP1 or MTAP supports malignancy
Loss of BAP1 nuclear expression or demonstration of CDKN2A deletion, often supported by MTAP loss, strongly supports malignant mesothelial proliferation against a reactive process. Sensitivity is incomplete, so retention does not exclude mesothelioma. Morphological invasion and clinicopathological correlation remain decisive; exposure history alone is not diagnostic.
Reference: ASCO guideline: treatment of malignant pleural mesothelioma. https://pmc.ncbi.nlm.nih.gov/articles/PMC8058628/